Introduction This article is the final part of our multi-blog series on analyzing the Draft Computer-Related Inventions (CRI) Guidelines, 2025. Part 1 discusses the new definitions and terms introduced in the Guidelines, Part 2 discusses the judgments referred to in the Guidelines, Part 3 discusses the novelty and inventive step sections and Part 4 discusses […]
Introduction This article is part 4 of our multi-blog series on analyzing the Draft Computer-Related Inventions (CRI) Guidelines, 2025. Part 1 discusses the new definitions and terms introduced in the Guidelines, Part 2 discusses the judgments referred to in the Guidelines, and Part 3 discusses the novelty and inventive step sections. On March 25, 2025, […]
Introduction This article is part 3 of our multi-blog series on the analysis of the Draft Computer Related Inventions (CRI) Guidelines, 2025. Part 1 of the series discusses the new definitions and terms introduced in the Guidelines and Part 2 discusses the judgements that have been referred to in the Guidelines. On March 25, 2025, […]
Introduction This article is part 2 of our multi-blog series on the analysis of the Draft Computer Related Inventions (CRI) Guidelines, 2025. Part 1 of the series discusses the new definitions and terms introduced in the Guidelines, and can be read here. On March 25, 2025, the Controller General of Patents, Designs, and Trade Marks […]
This article is part of our multi-blog series on the analysis of the Draft Computer Related Inventions (CRI) Guidelines, 2025. On March 25, 2025, the Controller General of Patents, Designs, and Trade Marks (CGPDTM) released Draft Revised Computer Related Inventions (CRI) Guidelines, 2025. The 2017 Guidelines have undergone significant changes to bring more clarity, precision, […]
Introduction The Indian Patents Act, 1970 plays a crucial role in defining what constitutes patentable subject matter. One of the most debated provisions is Section 3(k), which excludes the patenting of algorithms, business methods, and computer programs per se. In 2024, the Delhi High Court heard two key cases involving Blackberry Limited, which revolved around […]
Introduction Section 3(d) of the Indian Patent Act (hereinafter, “the Act”) bars the patentability of new uses or new forms of known compounds and compositions unless these changes result in significant therapeutic efficacy. Various judgments have established precedents clarifying non-patentability objections, particularly those under Section 3(d) of the Indian Patent Act. In a recent judgment […]